BiotechCannabisFeaturedNews

Will Sales Growth Save Cronos Group Inc. (NASDAQ: CRON) From selling Pressure?

[ad_1]

Will Sales Growth Save Cronos Group Inc. (NASDAQ: CRON) From selling Pressure?

Cronos Group Inc. (NASDAQ: CRON) stays below strain even on reporting a 274% year-over-year enhance in revenues within the latest quarter. The stock has been below strain since touching file highs of $11.90 early within the yr. The stock’s sentiments on the Street seem to have taken a success on a Canaccord Genuity’s analyst downgrading it to a ‘sell’ from a ‘hold’.

Given the strength of the downward strain, the stock stays inclined to additional declines because it continues to commerce close to a essential assist degree. A break adopted by an in depth beneath the $5.60 might open the door for the stock to plummet to the $3.20 deal with, seen as the following key assist degree.

However, provided that the long-term development factors to additional actions on the upside, the stock might make a push for its $52 week excessive on stabilizing above the essential assist degree.

Cronos Group is a diversified and vertically built-in firm that invests in entities which can be licensed or are in search of a license to provide medical marijuana in Canada. The firm additionally operates two wholly owned subsidiaries that deal in medical marijuana merchandise. In addition, it has a number of manufacturing and distribution platforms in Germany, Israel, and Australia.

Why is the stock dropping?

Cronos similar to different corporations with stakes within the marijuana stakes has come below strain on sentiments about investments within the sector taking a success. Investors have additionally pushed the stock decrease on a Canaccord Genuity analyst elevating considerations about its valuation given the meteoric rise final yr.

However, a steep decline in share worth can not in any method be attributed to the corporate’s underperformance.

Cronos Group Impressive numbers

Cronos Group seems to be doing nicely on the execution of its technique, if its fourth quarter and full yr earnings report is something to go by. Revenues within the fourth quarter had been up 274% to $1.6 million as full-year income elevated 636% to $4.1 million.

During the quarter, the corporate achieved numerous milestones together with completion of three indoor manufacturing amenities, anticipated to strengthen its manufacturing capability going ahead.

“We are building Cronos Group with a focus on the long-term and 2017 set the foundation for the explosive growth we have already started realizing in 2018. We are extremely proud of all that our team has accomplished and look forward to a year of rapid increases in sales, commencing distribution in new markets, said,” said Mike Gorenstein CEO of Cronos Group.

More Articles:

https://www.newswire.ca/news-releases/cronos-group-inc-announces-fourth-quarter-and-fiscal-year-2017-results-681220351.html

https://finance.yahoo.com/news/why-marijuana-stock-cronos-dropped-211900157.html?guccounter=1

https://www.newcannabisventures.com/cronos-group-2017-sales-reach-4-1-million/

[ad_2]

Source link

Disclaimer

This website is a wholly owned subsidiary of SCD Media, LLC, herein referred to as Smallcaps Daily. Our publications are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. We may receive compensation for this article on a PPC basis as an affiliate. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use. PLEASE NOTE WELL: Smallcaps Daily and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.Release of Liability: Through use of this website viewing or using you agree to hold Smallcaps Daily, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Smallcaps Daily encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and Smallcaps Daily makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provided herein. Instead Smallcaps Daily strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. Smallcaps Daily is compliant with the Can Spam Act of 2003. Salesparq, LLC does not offer such advice or analysis, and Smallcaps Daily further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results.In preparing this publication, Smallcaps Daily, has relied upon information supplied by its customers, publicly available information and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. Smallcaps Daily has not been compensated for this article. The advertisements in this website are believed to be reliable, however, Smallcaps Daily and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. Smallcaps Daily is not responsible for any claims made by the companies advertised herein, nor is Smallcaps Daily responsible for any other promotional firm, its program or its structure. Smallcaps Daily is not affiliated with any exchange, electronic quotation system, the Securities Exchange Commission or FINRA.
Show More

Related Articles

Trending Tickers

WISH
$9.18
27.72%
WISH
$9.18
27.72%
WISH
$9.18
27.72%
Back to top button